References
- LaiEStangPKao YangYKubotaKWongICSetoguchiSInternational multi-database pharmacoepidemiology: potentials and pitfallsCurr Epidemiol Rep201524229238
- LaiECManKKChaiyakunaprukNDatabases in the Asia-Pacific Region: the potential for a distributed network approachEpidemiology201526681582026133022
- VossEAMakadiaRMatchoAFeasibility and utility of applications of the common data model to multiple, disparate observational health databasesJ Am Med Inform Assoc201522355356425670757
- AndersenMBergmanUChoiNKThe Asian Pharmacoepidemiology Network (AsPEN): promoting multinational collaboration for pharmacoepidemiologic research in AsiaPharmacoepidemiol Drug Saf201322770070423653370
- PrattNAndersenMBergmanUMulti-country rapid adverse drug event assessment: the Asian Pharmacoepidemiology Network (AsPEN) antipsychotic and acute hyperglycaemia studyPharmacoepidemiol Drug Saf201322991592423696036
- RougheadEEChanEWChoiNKVariation in association between thiazolidinediones and heart failure across ethnic groups: retrospective analysis of large healthcare claims databases in six countriesDrug Saf201538982383126216600
- PrattNChanEWChoiNKPrescription sequence symmetry analysis: assessing risk, temporality, and consistency for adverse drug reactions across datasets in five countriesPharmacoepidemiol Drug Saf201524885886425907076
- OHDSI [homepage on the Internet]The Observational Health Data Sciences and Informatics2017 Available from: https://www.ohdsi.org/Accessed September 23, 2017
- homepage on the Internet Tawian National Health Insurance Administration2017 Available from: http://www.nhi.gov.tw/Accessed September 23, 2017
- StangPERyanPBRacoosinJAAdvancing the science for active surveillance: rationale and design for the Observational Medical Outcomes PartnershipAnn Intern Med2010153960060621041580
- XuYZhouXSuehsBTA comparative assessment of Observational Medical Outcomes Partnership and Mini-Sentinel common data models and analytics: implications for active drug safety surveillanceDrug Saf201538874976526055920
- OverhageJMRyanPBReichCGHartzemaAGStangPEValidation of a common data model for active safety surveillance researchJ Am Med Inform Assoc2012191546022037893
- ZhouXMurugesanSBhullarHAn evaluation of the THIN database in the OMOP Common Data Model for active drug safety surveillanceDrug Saf201336211913423329543
- National Library of Medicine [homepage on the Internet]National Institutes of Health Available from: http://www.nlm.nih.gov/Accessed September 23, 2017
- SNOMED [homepage on the Internet]NOMED International Available from: https://www.snomed.org/Accessed September 23, 2017
- WHO Collaborating Center for Drug Statistics Methodology [homepage on the Internet]Anatomical Therapeutic Chemical (ATC) Classification System Available from: http://www.whocc.noAccessed August 11, 2016
- HsiehSCLaiJNLeeCFHuFCTsengWLWangJDThe prescribing of Chinese herbal products in Taiwan: a cross-sectional analysis of the national health insurance reimbursement databasePharmacoepidemiol Drug Saf200817660961918481335
- RyanPBMadiganDStangPEOverhageJMRacoosinJAHartzemaAGEmpirical assessment of methods for risk identification in healthcare data: results from the experiments of the Observational Medical Outcomes PartnershipStat Med201231304401441523015364
- HripcsakGDukeJDShahNHObservational Health Data Sciences and Informatics (OHDSI): opportunities for observational researchersStud Health Technol Inform201521657457826262116